Research and Analytics
In the News
Research and Analytics
Remdesivir for 5 to 10 days in Patients with Severe COVID-19
Patients with severe cases of COVID-19 were treated with Remdesivir for 5 and 10 days to determine efficacy of the duration of treatment.
Providence Chief Pharmacy Officer on how his team has succeeded through the COVID-19 pandemic
Providence's Chief Pharmacy Officer shares how his team has overcome challenges with medication supply and drugs used to treat COVID-19.
Immunological manipulations to lessen the severity of COVID-19
Article featuring multiple Providence doctors published in the Journal for ImmunoTherapy of Cancer focused on immunological manipulations to lessen the severity of COVID-19.
Providence's George Diaz offers insights into Remdesivir
Dr. George Diaz, Infectious Disease Physician at Providence Regional Medical Center, is among the first doctors to use the drug Remdesivir in treating COVID-19. Learn more about Remdesivir.
Dr. Nicole Brooks shares the value of telehealth visits for patients during COVID-19
Find out how Providence is minimizing the exposure of COVID-19 with telehealth visits.
Three lessons learned from the outbreak by Dr. Rod Hochman
As Providence has been dealing with the coronavirus for three months now, Dr. Rod Hochman recounts the lessons learned.
Providence caregivers get quick access to mental health care amid pandemic
The service provides quick access to counseling by phone or video connection and has seen its highest volumes since its launch.
Frontline covers the coronavirus pandemic with Dr. Amy Compton-Phillips and Dr. George Diaz
Frontline investigates the American response to COVID-19 and examines what happens when politics and science collide.
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
Described in this case series are the first 12 US patients confirmed to have COVID-19 from January 20 to February 5, 2020.
Dr. Rod Hochman joins Becker’s Healthcare Podcast
Dr. Rod Hochman joins Becker’s Healthcare Podcast to discuss how Providence prepared itself to handle the COVID-19 pandemic.
As pandemic spreads, use of telehealth by clinicians and health systems surges
Dr. Gregg VandeKieft, palliative care specialist, began seeing clients through televisits for the first time in recent weeks and recounts his experience with the Catholic Health Association.
How a tech incubator inside is helping patients and caregivers
Providence digital leaders Aaron Martin and Sara Vaezy discuss how healthcare is benefiting from technological innovation.
Providence offering telehealth visits with primary care providers and specialists
Providence is offering the telehealth visits as an option to allow patients to remain safely in the comfort of their homes and still see their providers.
Facebook Live: The Technology of COVID
Sara Vaezy and Maryam Gholami join Mary Renouf to discuss technologies role in Providence's COVID-19 response.
Facebook Live: National Health Care Decision Day and COVID-19
Providence's Ira Byock, M.D. discusses.
Providence pivots digital consumer tools for COVID-19 response
Providence has been a leader in modernizing tools and pivoting digital consumer tools.
How Providence is responding to medication shortages and tips to manage drug supply
Providence created an incident command structure to anticipate emergent shortages of medications, supplies, services and operational challenges.
Providence hospital finds success using tele-monitoring to care for COVID-19 patients
COVID-19 has forced us to change the way we live and it's changed the way some doctors and nurses are providing care.
Providence offering telebehavioral health services for health care workers
Providence launched a telebehavioral health initiative earlier this year to address mental health issues among the organization's employees and their family members.
Reflecting on COVID-19 and tech transformations becoming reality
Dr. Amy Compton Phillips shares her perspective on technology and the COVID-19 response.
Facebook Live: Brette Borow, Founder of @TheHerFeed, speaks with Dr. Arpan Waghray, CMO of Well Being Trust
Brette Borow, Founder of @TheHerFeed, and Dr. Arpan Waghray, CMO of Well Being Trust discuss mental health and telehealth during the COVID-19 pandemic.
Blue Cirrus Radio Talk Show: Providence and Telehealth
The Providence Telehealth team shares our COVID-19 response with Blue Cirrus.
How health systems can care for front-line workers during the COVID-19 pandemic
Leadership across Providence created a set of principles to frame our actions and serve our 120,000 caregivers.
Telemedicine and COVID-19: What to Know Now
With relaxed restrictions on telemedicine, thousands of doctors are jumping on board. What to know, where to get help, and how to reassure your patients.
Facebook Live: How Providence is Helping in the Community During the COVID Pandemic
Providence's Laurie Kelley, Chief Philanthropy Officer talks with Dora Barilla, VP of Community Investment about how Providence is helping in the community during the COVID pandemic.
Milken Institute: A Conversation with Dr. Rod Hochman
Dr. Hochman shares the steps he's taken to prepare facilities, protect caregivers, and contain cases to a level that has, thus far, been manageable.
"We must make the hard choices now." - Dr. Robin Henderson
Behavioral health expert, Dr. Robin Henderson, sits down with Herfeed.com founder Brette Borow to discuss the psychological and mental strains of COVID-19.
Providence CEO, Dr. Rod Hochman, discusses with other health leaders on COVID-19 frontline stories
Dr. Rod Hochman joined health leaders on the first episode of PSBJ Straight Talk to share stories from the front lines of the coronavirus crisis.
Facebook Live: Fighting the COVID-19 Pandemic
Joel Gilbertson, Becca Bartles, Laurie Kelley, and Ira Byock share the different initiatives and programs Providence is providing during this crisis.
Modern Healthcare Webinar: COVID-19 — The Disruption No One Planned For
Providence's Dr. Amy Compton Phillips sits on an expert panel discussing the COVID-19 response.